Аденорм

Quick links to important sections

Аденорм

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Аденорм

What is Аденорм? (Tamsulosin Hydrochloride)

Property Description
Active ingredient Tamsulosin Hydrochloride (Tamsulosin HCl)
Form Sustained-release capsule (Oral Controlled Absorption System)
Pharmacological class Selective Alpha-Adrenergic Blocker (alpha1-antagonist)
General purpose To relax smooth muscles in the lower urinary tract
Origin Synthetic small molecule

What Type of Medication is Аденорм? (Classification and Composition)

Аденорм is a prescription-only medicinal product whose active component is the single substance Tamsulosin Hydrochloride (Tamsulosin HCl). This medicine belongs to the pharmacological class known as a selective alpha-adrenergic blocker, functioning as an alpha1-adrenoceptor antagonist. Tamsulosin HCl itself is a synthetic small molecule derived from the sulfonamide class, and Аденорм is offered as a single-ingredient preparation. Its focused action is a key differentiating factor among older, less selective alpha-blockers.

Аденорм's Form and Specialized Delivery System

The medication is administered orally in the form of a specialized sustained-release capsule, which is engineered for modified or controlled absorption. This is a crucial design element, often involving an Oral Controlled Absorption System (OCAS), which distinguishes it from immediate-release forms. This controlled delivery ensures the Tamsulosin active ingredient is released slowly and consistently over an extended period. This sustained-release mechanism is relevant for achieving stable drug levels and supporting patient convenience with once-daily dosing.

What is the General Purpose of Taking Аденорм? (High-Level Benefit)

The general purpose of taking Аденорм is derived from its action of selectively causing the relaxation of smooth muscles in the prostate gland and the neck of the bladder. By blocking specific alpha-1 adrenoceptors in these tissues, the medication reduces muscular tension. This relaxation action provides clinical benefit by facilitating the outflow of urine. Therefore, the medicine's primary benefit is to help increase the internal diameter of the urinary channel, making it easier to pass urine and thereby alleviating difficulties associated with muscular tension in the lower urinary tract.

Regulatory References

  1. NIH DailyMed

What side effects are possible with Аденорм?

Possible side effects and safety information

The official safety profile for Аденорм (Tamsulosin Hydrochloride) categorizes adverse reactions based on frequency and affected body systems, derived from regulatory data and clinical experience.

Common adverse reactions (occurring in 1% to 10% of patients) include dizziness, headache, and abnormal ejaculation. These effects are typically linked to the drug's mechanism as a selective alpha-blocker. Uncommon reactions may involve palpitations, orthostatic hypotension (postural drop in blood pressure), rhinitis, and gastrointestinal issues such as nausea and constipation.

Some safety concerns are more frequently observed at specific times. Regulatory documents note that the signs and symptoms of orthostatic hypotension and the potential for syncope (fainting) are most often observed at the start of treatment or following a dose increase.

Serious adverse reactions, though rare, include Angiooedema, Priapism, and severe dermatological conditions such as Stevens-Johnson Syndrome. Furthermore, Intraoperative Floppy Iris Syndrome (IFIS) is a specific safety concern that requires a patient's history of alpha1-blocker use to be communicated to the ophthalmologist before cataract or glaucoma surgery.

Formal safety limitations exist for specific patient populations. The medication is contraindicated in individuals with a history of orthostatic hypotension or known hypersensitivity to the drug. Caution is recommended in patients with end-stage renal disease and the drug is not studied in those with severe hepatic impairment, where its use is restricted.

Overdose and Emergency Response

The drug Аденорм (often associated with the active substance Tamsulosin, an alpha-1 blocker) can pose risks if taken in excess. Overdose with this class of medication can lead to pronounced cardiovascular effects due to its mechanism of action, which involves the relaxation of blood vessels.

Overdose and when to seek help

Overdose Scope

An overdose of Аденорм may lead to significant hypotension (low blood pressure) and tachycardia (rapid heartbeat) as the body attempts to compensate for the sudden drop in blood pressure. The severe drop in systemic blood pressure is the primary documented presentation of concern. Symptoms can include dizziness, fainting (syncope), and profound weakness. The physiological systems primarily affected are the cardiovascular system and, secondarily, the central nervous system due to reduced blood flow.

Required Emergency Action

Immediate and urgent medical attention is required for any suspected overdose. Seek emergency medical care (call 911 or local emergency services) immediately if you or someone else has taken more than the prescribed dose and experiences severe dizziness, fainting, or collapse. Supportive care is the core of treatment for this type of overdose.

Overdose Structure

Official Overdose Statements:

  • Overdose can result in severe hypotensive effects, potentially leading to syncope.
  • The primary concern is severe low blood pressure, which may require active medical intervention to restore circulatory volume and stabilize the patient.
  • In all cases of suspected overdose, contact emergency services or a poison control center for guidance.

Connection to the overall overdose profile

The regulatory and authoritative sources indicate that the main risk following an overdose of Аденорм is severe hypotension, which can be life-threatening if not addressed promptly. This adverse effect is directly linked to the drug's therapeutic mechanism of action, resulting in a systemic widening of blood vessels. The management of this overdose is largely supportive, focusing on restoring blood pressure through techniques like positioning the patient and administering intravenous fluids. Urgent medical help is necessary to monitor vital signs and prevent complications such as circulatory collapse. Given the potential for a rapid and significant drop in blood pressure, overdose of this agent is classified as requiring immediate medical intervention and stabilization in a clinical setting.

Therapeutic Uses of Аденорм

What Аденорм Treats: Main Uses and Benefits

Аденорм is primarily used to address symptomatic discomfort associated with specific clinical categories, offering targeted support for symptom management.

Management of Symptoms Related to Functional Strain

Аденорм is commonly used in clinical settings to address symptoms related to organ-specific functional stress. This medication is applied across domains where additional symptomatic support is needed, helping address symptom clusters that interfere with daily functioning. It is commonly used across conditions presenting with acute episodes. This application provides supportive relief when symptoms intensify, which contributes to easing the overall symptom load.

Assistance in Managing Fluctuating Symptom Patterns

The medication is relevant in conditions characterized by periods of heightened symptoms, which involve episodic or fluctuating manifestations. It is used in areas where short-term symptom management is appropriate, and may assist with managing symptoms that create noticeable physiological strain. It generally contributes to improved comfort during periods of heightened symptoms, supporting general well-being. This therapeutic support may be part of symptomatic management during phases where symptoms become more noticeable or temporarily overwhelming.

Quick Fact: Relevant for Symptoms that Interfere with Daily Functioning

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Аденорм — Official Regulatory Information

The eligibility for Аденорм (Tamsulosin Hydrochloride) is strictly defined by regulatory authorities based on population characteristics and pre-existing medical status. The medicine is primarily indicated for use only in Adult Males (aged 18 years and older).


Contraindications and Exclusions

Category Official Regulatory Statement
Absolute Contraindication Patients with a known history of hypersensitivity to tamsulosin hydrochloride or any component of the capsule formulation.
Sex and Age Exclusion Women (including pregnant and lactating individuals) and the Pediatric Population are not indicated for use; safety and efficacy have not been established.
Procedural Restriction Initiation of therapy is not recommended in patients who are scheduled for cataract or glaucoma surgery.

Use Under Restriction or Caution

Use is subject to caution or restricted in certain populations where adequate studies are lacking:

  • Severe Organ Impairment: Patients with severe hepatic impairment or end-stage renal disease are restricted populations because the drug’s exposure profile has not been studied in these specific groups.

The regulatory framework ensures that use is limited to the population in whom an established safety and efficacy profile exists, with specific exclusions for vulnerable and unstudied groups.

What should I know about interactions with other medicines?

Аденорм Interactions with other medicines and products

The official regulatory documents for tamsulosin hydrochloride detail specific interaction patterns that affect systemic exposure and blood pressure control, which must be managed according to label restrictions.


Formal Contraindicated Combinations

Co-administration of tamsulosin with other alpha-adrenergic blocking agents (such as doxazosin or alfuzosin) is formally contraindicated. This restriction is documented due to the potential for severe, additive blood pressure lowering effects.


Pharmacokinetic (Exposure-Altering) Interactions

Interactions involving the metabolism of tamsulosin can significantly increase plasma concentrations. Co-administration with strong CYP3A4 inhibitors (like ketoconazole) or moderate CYP2D6 inhibitors (like paroxetine) results in reduced drug clearance and a documented increase in systemic exposure.


Pharmacodynamic (Additive) Interactions

Use with certain medicinal products carries a risk of additive pharmacologic effects. Co-administration with Phosphodiesterase-5 (PDE5) inhibitors (such as sildenafil) or other antihypertensive agents may produce additive blood pressure lowering effects.


Administration Timing Rule

The sustained-release formulation of tamsulosin is subject to a mandatory condition of use: it must be administered following a meal. This timing rule is officially stated to ensure the proper absorption and controlled delivery of the medication.


Population-Specific Note

Regulatory authorities note that the interaction profile in patients with severe hepatic impairment has not been specifically studied, leading to a caution regarding potential altered clearance in this population.

Mechanism of Action

How Аденорм Works

The mechanism of Аденорм (Tamsulosin Hydrochloride) involves interaction with specific receptors that mediate muscle tension in the lower urinary system, resulting in defined physiological consequences.


Selective Blockade of Alpha-1 Adrenoceptors

The primary action involves acting as a selective antagonist that physically blocks the Alpha-1 adrenoceptor (alpha1-AR) subtypes, primarily alpha1 A and alpha1 D, found on the smooth muscle cells of the prostate and bladder neck. This targeted blockade prevents the binding of the body's natural signaling molecule, norepinephrine, which would otherwise initiate the signal for muscle contraction.


Modulation of Sympathetic Tone and Smooth Muscle Relaxation

By disrupting the sympathetic nervous system signaling pathway at the receptor level, Аденорм decreases the neurogenically-driven muscle tone in the urethral channel. This molecular cascade leads to the relaxation of smooth muscle tissue in the prostate and bladder neck, which is a direct physiological consequence of the alpha1-blockade.


Increased Functional Diameter of the Urinary Channel

The relaxation of these key smooth muscles reduces the constrictive pressure on the prostatic urethra. The resulting change is an increase in the functional cross-sectional diameter of the channel, which causes a lower resistance to fluid outflow. This mechanism acts on the dynamic (muscle-tension) component of the physiology but does not alter the physical size or volume of the prostate gland.

Dosage and Administration Information

Official Administration Guidelines for Tamsulosin Hydrochloride

Аденорм (Tamsulosin Hydrochloride) is designated exclusively for oral administration in the form of a sustained-release capsule or prolonged-release tablet. The capsule must be swallowed whole and should not be crushed, chewed, or opened, as this action interferes with the intended modified-release mechanism.


Standard Regimen and Dosing Schedule

Administration is standardized as once daily. The recommended starting dose for adults is 0.4 mg. This base dose is maintained for two to four weeks, after which the dosage may be considered for increase to a maximum of 0.8 mg once daily if the initial response is insufficient.

Dosing Parameter Official Instruction
Starting Dose 0.4 mg once daily
Maximum Dose 0.8 mg once daily
Timing (US Capsule) Approximately one-half hour following the same meal each day

Use-Specific Instructions

Consistent adherence to the prescribed timing is a key procedural component of therapy. If administration is discontinued or interrupted for several days, therapy must be restarted at the initial 0.4 mg dose. The medication is not indicated for use in the pediatric population (individuals under 18 years of age). For adult patients with mild to moderate renal or hepatic impairment, no dosage adjustment is generally required, though there are insufficient data for patients with severe impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Аденорм

The primary research body for the active ingredient in Аденорм, Tamsulosin, comes from short-term, randomized controlled trials (RCTs). These pivotal studies were designed to examine measured outcomes in adult men presenting with BPH-related lower urinary tract symptoms (LUTS). The research was conducted using these controlled designs to compare the outcomes measured in men taking the active drug against men taking an inactive placebo pill.

These short-term studies monitored patient-reported outcomes describing perceived discomfort. Specifically, researchers used standardized tools, such as the International Prostate Symptom Score (IPSS), to track symptom intensity or variability. The trials also included objective assessments of physical function, such as studies monitoring the maximum speed of urine flow (Q max) and the amount of urine remaining in the bladder after voiding (Post-Void Residual, PVR). Research reports patterns observed in the measurement of these symptom scores and functional measures when compared to placebo across the study periods.

Measures Evaluated in Clinical Trials

The main focus of research has been on patient-reported outcomes describing perceived discomfort associated with conditions characterized by fluctuating or episodic manifestations. Studies specifically explored changes in outcomes related to physical discomfort linked to functional limitations, such as urgency, frequency, and weak stream. Findings describe patterns observed in the studies related to the change in these symptom clusters over defined time intervals, usually 4 to 13 weeks.

Long-Term Evidence and Durability of Follow-up

While the initial outcome data comes from controlled, short-term trials, the question of whether measured outcomes persist was evaluated in long-term extension studies. These studies involved patients who chose to continue treatment, and the research often tracked them for periods extending up to four to six years. However, these studies essentially observed the patterns of symptomatic and functional measurements over the years and are not randomized or placebo-controlled.

Key Limitations and Remaining Research Gaps

The most significant limitation is that the follow-up durations were limited in the pivotal, placebo-controlled trials. This means there is limited information for outcomes where long-term follow-up is necessary, and research does not determine the change in the overall progression of BPH symptoms over decades. Data for certain groups, such as those with severe kidney or liver impairment, remain insufficient, and research does not determine a lasting outcome.

Key Studies & References

  1. Tamsulosin hydrochloride capsule, sustained release (NIH DailyMed)
  2. Tamsulosin (NIH MedlinePlus Drug Information)

Frequently Asked Questions (FAQ)

Common questions about Аденорм (FAQ)


Q: Is Аденорм the same as Tamsulosin?

The active ingredient in the branded product, Аденорм, is Tamsulosin Hydrochloride. Tamsulosin is the generic name for the same medication, meaning they contain the exact same primary drug substance.


Q: What conditions is Аденорм primarily used to treat?

According to official product information, Аденорм is primarily indicated for treating the signs and symptoms of benign prostatic hyperplasia (BPH). This condition involves the non-cancerous enlargement of the prostate gland.


Q: How quickly should I expect to see results from Аденорм?

Regulatory documents indicate that the dose may be considered for increase after two to four weeks of dosing if the initial response is not sufficient. This timeframe is used by healthcare providers to evaluate the initial symptomatic response to the medication, and individual results can vary.


Q: Do I need to take Аденорм with food?

Yes, official regulatory documents state that Аденорм must be taken with food. It is required to be administered approximately one-half hour following the same meal each day. This procedure helps ensure proper absorption and can minimize certain adverse effects.


Q: Can Аденорм cause dizziness or lightheadedness?

Yes, dizziness is a common adverse event reported in clinical trials. The medication can also cause a drop in blood pressure when moving to a standing position (known as orthostatic hypotension), which may result in feelings of lightheadedness or fainting. These effects are often most noticeable when treatment begins or after a change in dosage.


Q: Is it normal to feel tired when starting Аденорм?

Yes, some patients in clinical trials reported experiencing asthenia (physical weakness or lack of energy) and somnolence (drowsiness). These effects are listed as treatment-emergent adverse events in the official product information.


Q: What happens if I accidentally miss a dose of Аденорм?

Regulatory guidance suggests that if a single dose is missed, patients should consult the patient information leaflet. Official information advises against taking two doses at once to compensate for a missed dose. If a whole day is missed, patients should generally continue with the next dose on their regular schedule.


Q: What should I avoid drinking or eating while taking Аденорм?

The medication is required to be taken with a meal for proper absorption. Additionally, Grapefruit juice should be avoided as it can interfere with how the drug is metabolized in the body, potentially increasing its effects and adverse reactions.


Q: Is it safe to drink alcohol in moderation while on Аденорм?

Official warnings state that alcohol may need to be avoided while taking this medication. Tamsulosin is an alpha-blocker, and alcohol may have additive blood pressure-lowering effects which can increase the risk of symptoms like dizziness and symptomatic hypotension.


Q: When is the best time of day to take Аденорм?

The medication should be taken once daily approximately one-half hour following the same meal each day. This procedural requirement helps to maintain consistent drug levels in the body, regardless of whether that meal is breakfast or dinner.


Q: Can Аденорм be cut in half or crushed?

No. The capsules are designed as a sustained-release formulation. Official instructions require the capsules to be swallowed whole and they must not be crushed, chewed, or opened, as this would interfere with the controlled-release system.


Q: Is there a generic version of Аденорм available?

Yes. The active ingredient, Tamsulosin Hydrochloride, is widely available in generic formulations.


Q: Can Аденорм interact with herbal supplements?

Official product labels primarily address drug-drug interactions, and there is generally not enough safety information to confirm that herbal remedies or complementary medicines are safe to take alongside Tamsulosin. Patients are encouraged to discuss all supplements with a healthcare professional.


Q: Why do some people experience nasal congestion on Аденорм?

Nasal congestion, or rhinitis, is a reported side effect of the medication. The drug works as an alpha-blocker, which relaxes smooth muscles throughout the body. The relaxation of these muscles in the nasal passages is considered the reason for this side effect.


Q: How is Аденорм eliminated from the body?

According to official pharmacology data, Tamsulosin is extensively metabolized (broken down) primarily in the liver. Most of the drug's components (approximately 76%) are then recovered and eliminated from the body through the urine.


Q: Can I drive or operate machinery while taking Аденорм?

Caution is advised for activities that require full mental alertness, such as driving or operating hazardous machinery. Because the drug can cause dizziness and a drop in blood pressure, patients should wait until they know how the medication affects them before engaging in these activities.


Q: How long does the effect of one dose of Аденорм last?

The medication is formulated as a sustained-release capsule and is designed to be taken once daily. This design ensures that the therapeutic effects of the drug are intended to be maintained consistently throughout the 24-hour dosing period.


Q: Does Аденорм cause sexual dysfunction other than ejaculation issues?

Yes. In addition to abnormal ejaculation (which is a common side effect), official adverse event reports include a decrease in libido (sex drive). There have also been rare reports of priapism (a painful, long-lasting erection) associated with its use.


Q: Will Аденорм cure my condition, or just manage the symptoms?

The drug is indicated to treat and manage the signs and symptoms of BPH by relaxing muscles in the urinary tract. Official information indicates that it is not intended to cure the underlying condition or reduce the physical size of the enlarged prostate gland.


Q: Is Аденорм used for problems other than prostate enlargement?

In the United States, Аденорм is indicated only for the treatment of the signs and symptoms of BPH. Official labeling specifically states that it is not indicated for the treatment of other conditions, such as hypertension (high blood pressure).


Q: What happens if I stop taking Аденорм suddenly?

If the medication is discontinued or interrupted for several days, official guidance is to restart therapy at the initial, lowest recommended dose. It is important for patients to consult a healthcare provider for specific instructions before restarting treatment.

How should Аденорм be stored and disposed of?

The storage and disposal instructions for Аденорм (tamsulosin hydrochloride) are based on official regulatory requirements to maintain product stability and safety.

Storage Conditions

Аденорм must be stored at room temperature, ensuring the environment is away from excess heat and moisture. It is explicitly required to keep from freezing.

Container and Safety

The medicine must be kept in the original container in which it was dispensed, and the container must remain tightly closed. Storage must be out of the sight and reach of children.

Disposal Instructions

Disposal of any unused or expired Аденорм must strictly follow local requirements and applicable laws. Patients should consult a healthcare professional or pharmacist for guidance on proper discarding procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Аденорм found in:

A-Z Index: